Seven different postoperative complications occurred two to four times more often in patients who had a history of intravitreal drug injections as compared with those who did not. Among complications ...

Findings of the PANORAMA randomized clinical trial show that when patients with severe nonproliferative diabetic retinopathy were treated with intravitreal aflibercept, severity improved over 100 ...

Please provide your email address to receive an email when new articles are posted on . Two-year results of an ongoing study show that intravitreal aflibercept injections in eyes with baseline ...

Please provide your email address to receive an email when new articles are posted on . When performing cataract surgery in patients treated with intravitreal injections, be aware of the increased ...

Jose Martinez, MD: When we assess patients and we’re trying to consider whether to use anti-VEGF [anti-vascular endothelial growth factor], one thing we consider is their ability to come back and see ...

Intravitreal injections with aflibercept (Eylea) don't improve the visual acuity of people with nonproliferative diabetic retinopathy (NPDR), researchers say. The treatments do reduce the risk for ...

Eye injections are the only medication currently available to treat diabetes-related retinopathy. Modern eye injections are not painful and don’t cause many side effects. Diabetic retinopathy affects ...